{
    "code": "02025092",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025092",
    "time": "2019-09-06 03:03:22",
    "許可證字號": "衛署藥輸字第025092號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/09\/18",
    "發證日期": "98\/09\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202509209",
    "中文品名": "肺舒坦定量吸入劑 100\/6mcg\/dose",
    "英文品名": "Foster",
    "適應症": "氣喘:\r\nFoster適用於需規律使用吸入型皮質類固醇與長效beta 2致效劑合併治療的氣喘病患。\r\n慢性阻塞性肺病(COPD):\r\n患有較嚴重之慢性阻塞性肺病(FEV1少於預測值之50%)及有反覆惡化病史，已定期使用長效型支氣管擴張劑，而仍有明顯症狀病患之治療。",
    "劑型": "103口腔吸入劑",
    "包裝": "100 毫升以下鋁罐瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "FORMOTEROL FUMARATE DIHYDRATE, BECLOMETHASONE DIPROPIONATE",
    "主製造廠": {
        "申請商名稱": "0416601100  友華生技醫藥股份有限公司",
        "申請商地址": "台北市復興南路一段３６８號７樓",
        "主製造廠": "",
        "製造廠名稱": "FIT0041200  CHIESI FARMACEUTICI S.P.A."
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216003030",
            "成分名稱": "FORMOTEROL FUMARATE DIHYDRATE",
            "含量描述": "",
            "含量": "0.0060000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8406000310",
            "成分名稱": "BECLOMETHASONE DIPROPIONATE",
            "含量描述": "",
            "含量": "0.1000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "中文仿單_final_20190820-108-08-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025092&Seq=008&Type=9"
        },
        {
            "title": "藥輸字第025092號_Foster外盒-108-05-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025092&Seq=002&Type=8"
        }
    ]
}